Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

297 Views

047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Treatment

(538) Clinical Evaluation of Drug-drug Interactions with Remdesivir

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

CP

Chi-Chi Peng, PhD

Sr. Clinical Pharmacologist II
Gilead Sciences, Inc.
Foster City, California, United States

Co-Author(s)

MS

Mark Shelton, PharmD

Gilead Sciences, Inc.
Foster City, California, United States
AR

Anuja Raut, MS, MS

Gilead Sciences, Inc.
Foster City, California, United States
AK

Anna Kwan, BS

Gilead Sciences, Inc.
Foster City, California, United States
KC

Kanika Chhabra, MS

Gilead Sciences, Inc.
Foster City, California, United States
GS

Gong Shen, PhD

Gilead Sciences, Inc.
Foster City, California, United States
DX

Deqing Xiao, PhD

Gilead Sciences, Inc.
Foster City, California, United States

Presenting Author(s)

AK

Aryun Kim, PharmD

Principal Scientist
Gilead Sciences, Inc.
Foster City, California, United States

Co-Author(s)

SM

Sharline Madera, MD, PhD

Gilead Sciences, Inc.
Foster City, California, United States
RH

Robert H. Hyland, DPhil

Gilead Sciences, Inc.
Foster City, California, United States
HW

Helen Winter, PhD

Gilead Sciences, Inc.
Foster City, California, United States
RH

Rita Humeniuk, PhD

Gilead Sciences, Inc.
Foster City, California, United States